| Oral Lactobacillus Crispatus Lc-G22 as Adjunctive Therapy for Vulvovaginal Candidiasis (NCT07727967) | BioGrowing Co., Ltd | 2022-07-01 |
| Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis. (NCT05031481) | EMS | 2022-07-01 |
| VVC Sampling Study for Analysis Validation (NCT05327192) | Gedea Biotech AB | 2022-05-12 |
| Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis (NCT05399641) | Scynexis, Inc. | 2022-05-01 |
| Comparative Performance of a Vaginal Yeast Test (NCT05079711) | Uniformed Services University of the Health Sciences | 2022-03-18 |
| Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis (NCT05012852) | PepTonic Medical AB | 2021-09-01 |
| Comparison of Boric Acid vs. Terconazole in Treatment of RVVC (NCT04208555) | Hatem AbuHashim | 2020-01-15 |
| Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal Candidiasis (NCT03761628) | Gedea Biotech AB | 2019-01-07 |
| Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis (NCT02907307) | Medinova AG | 2018-12-01 |
| Patients With Vulvovaginal Candidiasis (NCT03024502) | University of Sao Paulo | 2018-01-30 |
| TOL-463 Phase 2 Study for Vaginitis (NCT02866227) | Toltec Pharmaceuticals, LLC | 2016-07-15 |
| Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis (NCT02679456) | Scynexis, Inc. | 2015-11-01 |
| Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis (NCT02242695) | Medinova AG | 2014-11-01 |
| Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis (NCT02203942) | University of Pittsburgh | 2014-07-01 |
| Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis (NCT02180100) | Peking University Shenzhen Hospital | 2013-08-01 |
| Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis (NCT01926028) | NovaDigm Therapeutics, Inc. | 2013-07-01 |
| The Study Of Fluconazole For Vulvovaginal Candidiasis (NCT01806623) | Pfizer | 2013-03-05 |
| Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women (NCT02150655) | Western University, Canada | 2012-09-01 |
| Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment (NCT01144286) | Ferrer Internacional S.A. | 2010-06-01 |
| Comparative Efficacy of Ovule vs Tablet (NCT00755053) | Bayer | 2008-09-01 |
| Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina (NCT00194324) | University of Pennsylvania | 2004-07-01 |
| Diabetes Mellitus and Vulvovaginal Candidiasis (NCT00353561) | Indian Council of Medical Research | 2004-06-01 |
| Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis (NCT00803738) | Padagis LLC | 2002-12-01 |
| Monthly Itraconazole Versus Classic Homeopathy for Treatment of Recurrent Vulvovaginal Candidiasis (RVVC) (NCT00895453) | Medical University of Vienna | 2000-05-01 |